Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
1.800
-0.050 (-2.70%)
At close: Feb 21, 2025, 4:00 PM
1.780
-0.020 (-1.11%)
After-hours: Feb 21, 2025, 6:11 PM EST
Citius Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Feb '25 Feb 21, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Market Capitalization | 15 | 90 | 109 | 177 | 296 | 58 | |
| Market Cap Growth | -74.30% | -16.79% | -38.51% | -40.33% | 413.63% | 164.13% | |
| Enterprise Value | 15 | 73 | 77 | 130 | 182 | 51 | |
| Last Close Price | 1.80 | 12.52 | 17.11 | 30.25 | 50.75 | 26.00 | |
| Forward PE | 1.02 | 8.71 | - | - | - | - | |
| PB Ratio | 0.21 | 1.22 | 1.19 | 1.71 | 2.23 | 1.71 | |
| P/TBV Ratio | - | - | 4.92 | 5.19 | 4.67 | 11.72 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.04 | |
| Quick Ratio | 0.02 | 0.09 | 4.58 | 9.21 | 17.60 | 3.38 | |
| Current Ratio | 0.41 | 0.40 | 5.95 | 9.84 | 18.28 | 3.41 | |
| Return on Equity (ROE) | -52.48% | -47.63% | -33.40% | -28.48% | -27.70% | -57.70% | |
| Return on Assets (ROA) | -24.47% | -23.83% | -21.10% | -16.24% | -15.80% | -27.49% | |
| Return on Capital (ROIC) | -34.46% | -31.57% | -23.42% | -17.52% | -17.44% | -35.51% | |
| Earnings Yield | -263.27% | -43.26% | -29.93% | -19.03% | -7.78% | -30.42% | |
| FCF Yield | -173.21% | -31.17% | -26.73% | -16.04% | -8.19% | -29.35% | |
| Buyback Yield / Dilution | -13.45% | -11.16% | -3.57% | -34.52% | -177.28% | -94.25% | |
| Total Shareholder Return | -13.45% | -11.16% | -3.57% | -34.52% | -177.28% | -94.25% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.